EFFECTİVİTY OF CHITOSAN COVERED GAUZE IN POSTPARTUM HEMORRHAGIC OBSTETRIC LACERATIONS

Launched by ISTANBUL TRAINING AND RESEARCH HOSPITAL · May 22, 2025

Keywords

ClinConnect Summary

This clinical trial is investigating how effective a special type of gauze, covered with a substance called chitosan, is at stopping bleeding from tears that can happen during childbirth. The study will compare this new treatment to the traditional method of stitching up the tears. Women who have recently given birth and are experiencing certain types of tears with bleeding may be eligible to participate. Specifically, the study is looking for women aged 18 to 48 who have given birth in Istanbul between March 2025 and March 2027 and have first or second-degree lacerations without other complications.

Participants in the trial can expect to be evaluated during their hospital stay after delivery and again six weeks later during a routine postpartum check-up. The treatments will be assigned randomly, meaning some women will receive the chitosan gauze while others will receive stitches. This study aims to find out which method is better at stopping bleeding and could help improve care for new mothers in the future.

Gender

FEMALE

Eligibility criteria

• • Inclusion Criteria: Patients, 18-48 years old, who gave birth in Istanbul TRH between March 2025 and March 2027 experiencing 1st and 2nd degree obstetric lacerations with postpartum hemorrhage without the need for anatomical defect repairing and without additional conditions such as uterine atony, placental rest, etc. that may affect the amount of postpartum bleeding.
• • Exclusion Criteria: Patients not fullfilling the inclusion criteria in terms of age limits, time and place of birth or ones who are experiencing 1st and 2nd degree obstetric lacerations with postpartum hemorrhage with the need for anatomical defect repairing and with additional conditions such as uterine atony, placental rest, etc. that may affect the amount of postpartum bleeding.